Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed Nov 10, 2016 · 10-Q · 41 days after period end · 0001193125-16-765868
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $785.01K | $414.61K | $18.72K |
| Net Income | -$6.20M | -$3.92M | -$2.02M |
| EPS Diluted | -$0.14 | -$0.10 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 10, 2016 · 41 d after period end
